An ongoing shortage of albuterol, a critical medicine for treating breathing problems, has intensified following the shutdown of a major supplier to U.S. hospitals. STAQ Pharma, a hospital-owned 503B outsourcing supplier, has been instrumental in addressing this crisis by producing compounded pediatric albuterol medications to meet the needs of children’s hospitals. As supply chain issues persist, STAQ Pharma is committed to ensuring a steady and stable supply of essential medications, highlighting their pivotal role in combating drug shortages and supporting healthcare systems nationwide.
Read more from a CNN Health report, noting STAQ’s partnership with the Children’s Hospital Association in helping children’s hospitals get ahead of the problem.